Adam Schoenfeld, Thoracic Medical Oncologist at Memorial Sloan Kettering Cancer Center, shared a post on X:
“Excited to share our article in Cancer Cell on clinical and molecular features of acquired resistance to immunotherapy in lungcancer.
We identify acquired resistance occurs in over >60% of initial responders and investigate underlying mechanisms.”
Title: Clinical and molecular features of acquired resistance to immunotherapy in non-small cell lung cancer
Authors: Danish Memon, Adam Schoenfeld, Darwin Ye, George Fromm, Hira Rizvi, Xiang Zhang, Mohamed Reda Keddar, Divij Mathew, Kyung Jin Yoo, Jingya Qiu, Jayon Lihm, Jayalaksmi Miriyala, Jennifer Sauter, Jia Luo, Andrew Chow, Umesh Bhanot, Caroline McCarthy, Chad Vanderbilt, Cailian Liu, Mohsen Abu-Akeel, Andrew Plodkowski, Nicholas McGranahan, Marta Łuksza, Benjamin Greenbaum, Taha Merghoub, Ikbel Achour, Carl Barrett, Ross Stewart, Pedro Beltrao, Taylor Schreiber, Andy Minn, Martin Miller, Matthew Hellmann
Other articles featuring Adam Schoenfeld on OncoDaily.
